"Leishmaniasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Descriptor ID |
D007896
|
| MeSH Number(s) |
C03.752.300.500 C03.858.560 C17.800.838.775.560
|
| Concept/Terms |
Leishmaniasis- Leishmaniasis
- Leishmaniases
- Leishmania Infection
- Infection, Leishmania
- Infections, Leishmania
- Leishmania Infections
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis".
This graph shows the total number of publications written about "Leishmaniasis" by people in this website by year, and whether "Leishmaniasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis" by people in Profiles.
-
Ogungbe IV, Setzer WN. In-silico Leishmania target selectivity of antiparasitic terpenoids. Molecules. 2013 Jul 03; 18(7):7761-847.
-
Pieroni M, Girmay S, Sun D, Sahu R, Tekwani BL, Tan GT. Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents. ChemMedChem. 2012 Nov; 7(11):1895-900.
-
Misra S, Tripathi MK, Chaudhuri G. Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages. J Biol Chem. 2005 Aug 12; 280(32):29364-73.
-
Calvopina M, Armijos RX, Hashiguchi Y. Epidemiology of leishmaniasis in Ecuador: current status of knowledge -- a review. Mem Inst Oswaldo Cruz. 2004 Nov; 99(7):663-72.
-
Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S, Ouellette M, Rosen BP, Mukhopadhyay R. Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem. 2004 Jul 23; 279(30):31010-7.
-
Armijos RX, Weigel MM, Romero L, Garcia V, Salazar J. Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last? J Infect Dis. 2003 Jun 15; 187(12):1959-61.
-
Mishra M, Porter-Kelley JM, Singh PK, Bennett JR, Chaudhuri G. Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions. Biochem Pharmacol. 2001 Sep 01; 62(5):569-80.
-
Armijos RX, Chico ME, Cruz ME, Guderian RH, Kreutzer RD, Berman JD, Rogers MD, Gr?gl M. Human cutaneous leishmaniasis in Ecuador: identification of parasites by enzyme electrophoresis. Am J Trop Med Hyg. 1990 May; 42(5):424-8.
-
Glew RH, Saha AK, Das S, Remaley AT. Biochemistry of the Leishmania species. Microbiol Rev. 1988 Dec; 52(4):412-32.